1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Paroxysmal Nocturnal Hemoglobinuria Market
2.3. Global Paroxysmal Nocturnal Hemoglobinuria Market, By Treatment, 2025 (US$ Million)
2.4. Global Paroxysmal Nocturnal Hemoglobinuria Market, By Geography, 2025 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2025
3. Paroxysmal Nocturnal Hemoglobinuria Market: Competitive Analysis
3.1. Market Positioning of Key Paroxysmal Nocturnal Hemoglobinuria Market Vendors
3.2. Strategies Adopted by Paroxysmal Nocturnal Hemoglobinuria Market Vendors
4. Paroxysmal Nocturnal Hemoglobinuria Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Paroxysmal Nocturnal Hemoglobinuria Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape
5. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Blood Transfusion
5.3.2. Medication
5.3.3. Stem Cell Transplant
6. North America Paroxysmal Nocturnal Hemoglobinuria Market, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
6.3. Paroxysmal Nocturnal Hemoglobinuria Market: By Region, 2024-2034, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
7. UK and European Union Paroxysmal Nocturnal Hemoglobinuria Market, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
7.3. Paroxysmal Nocturnal Hemoglobinuria Market: By Region, 2024-2034, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
7.3.1.5. France
7.3.1.5.1. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
8. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria Market, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
8.3. Paroxysmal Nocturnal Hemoglobinuria Market: By Region, 2024-2034, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
8.3.1.3. India
8.3.1.3.1. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
9. Latin America Paroxysmal Nocturnal Hemoglobinuria Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
9.3. Paroxysmal Nocturnal Hemoglobinuria Market: By Region, 2024-2034, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
10. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
10.3. Paroxysmal Nocturnal Hemoglobinuria Market: By Region, 2024-2034, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Paroxysmal Nocturnal Hemoglobinuria Market: By Treatment, 2024-2034, USD (Million)
11. Company Profile
11.1. Amgen, Inc. (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
11.2. Achillion Pharmaceuticals
11.3. Alexion Pharmaceutcials, Inc.
11.4. Akari Therapeutics
11.5. Apellis Pharmaceutcials, Inc.
11.6. CinnaGen
11.7. F.Hoffman-La Roche Ltd.
11.8. Novartis AG
11.9. Ra Pharmaceuticals
11.10. Regeneron Pharmaceuticals
